Medical News

RSS

Kaiser Permanente provides $1 million grant to increase access to food for all Coloradans

Each day, one in seven Coloradans face hunger. It's a serious issue that forces many to choose between putting food on the table and handling day-to-day expenses like paying the bills or purchasing necessary medication. Kaiser Permanente Colorado is reaffirming its commitment to diminishing the rates of hunger in this state by providing 13 local nonprofits a portion of a $1 million grant that aims to increase access to food for all Coloradans.

15 Mar 2016

ACI announces investment in Sphera Bluoshen to support development of healthcare technology

Angola Capital Investments, a leading international investment firm headquartered in Angola, announced its investment in Sphera Bluoshen S.A. to support the development of the finest healthcare technology around the globe.

15 Mar 2016

CardiacAssist's new TandemLung oxygenator receives FDA clearance

CardiacAssist, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood.

15 Mar 2016

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

DelMar Pharmaceuticals, Inc., announced today that the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for its lead product candidate, VAL-083, in the treatment of medulloblastoma.

15 Mar 2016

Pittcon 2015: Bruker introduces InsightMR software for on-line NMR analysis of chemical processes

Bruker is launching InsightMR software for on-line NMR analysis of chemical processes at Pittcon 2015. For the first time, a software platform enables the adjustment of experimental parameters based on real time data during the analysis of chemical processes by NMR spectroscopy.

From Bruker BioSpin Group 15 Mar 2016

Bruker expands capabilities of NMR-based Assure-RMS solution with launch of Chemometrics Module

Bruker Corporation introduces the Chemometrics Module, further expanding the capabilities of its proven Assure-RMS solution. Fully automated, quantitative and qualitative Nuclear Magnetic Resonance (NMR) analysis enables material screening in the polymer, pharmaceutical and dietary supplement industries.

From Bruker BioSpin Group 15 Mar 2016

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

Bruker Corporation introduces Assure – Aloe, an NMR-based solution for Aloe Vera quality control. Fully automated, quantitative and qualitative Nuclear Magnetic Resonance (NMR) analysis enables Aloe vera material screening in the cosmetics, natural products and pharmaceutical industries.

From Bruker BioSpin Group 15 Mar 2016

BD MedMined Surveillance Advisor finishes first in Infection Control and Monitoring category

BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.

15 Mar 2016

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

At the 56th Experimental Nuclear Magnetic Resonance Conference, Bruker this week is show-casing several innovative drug discovery, drug development and process control solutions for small molecule NMR characterization in the pharmaceutical industry.

From Bruker BioSpin Group 15 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Study could lead to potential new therapeutic target with fewer side effects for hypertension

A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension - a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.

15 Mar 2016

Learning complex tactile tasks activates the visual cortex

Biology lessons teach us that the brain is divided into separate areas, each of which processes a specific sense. But findings to be published in eLife show we can supercharge it to be more flexible.

15 Mar 2016

Children who receive little to no nutrition during first week in intensive care recover faster

Critically ill children are artificially fed soon after their arrival in intensive care. This common practice is based on the assumption that it will help them recover more quickly. An international study coordinated at KU Leuven, Belgium, has now disproven this theory. The study shows that receiving little to no nutrition during the first week in intensive care makes children recover faster.

15 Mar 2016

Aralez resubmits NDA package for YOSPRALA to FDA

Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

15 Mar 2016

Researchers provide new mechanism for age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.

15 Mar 2016

Ibrutinib and idelalisib drugs for chronic lymphatic leukaemia can prolong survival time of high-risk patients

Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly prolong the survival time of high-risk patients.

15 Mar 2016

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.

15 Mar 2016

UCSF study marks important step toward finding cure for Ebola

In experiments carried out partly at the Department of Energy's SLAC National Accelerator Laboratory, scientists have determined in atomic detail how a potential drug molecule fits into and blocks a channel in cell membranes that Ebola and related "filoviruses" need to infect victims' cells.

15 Mar 2016

Prognostic test could help lower cancer recurrence for colorectal patients

Colorectal cancer, one of the most commonly diagnosed cancers in the United States, is not a commonly discussed disease. Often symptomless in early stages, the cancer is more difficult to treat as it progresses, requiring chemotherapy in later stages. Researchers at the University of Notre Dame are working on a way to identify patients who would benefit from chemotherapy before the cancer progresses.

15 Mar 2016

New blood test may potentially facilitate detection of Alzheimer's disease at early stage

Today, Alzheimer's disease is diagnosed too late. In collaboration with a research team at the university and German Center for Neurogenerative Diseases in Göttingen, Researchers at Ruhr-Universität Bochum have developed a blood test that may potentially facilitate detection of Alzheimer's at an early stage. It is based on an immuno-chemical analysis using an infrared sensor.

15 Mar 2016

Medical News

Kaiser Permanente provides $1 million grant to increase access to food for all Coloradans

ACI announces investment in Sphera Bluoshen to support development of healthcare technology

CardiacAssist's new TandemLung oxygenator receives FDA clearance

DelMar's VAL-083 receives FDA orphan drug designation for treatment of medulloblastoma

Pittcon 2015: Bruker introduces InsightMR software for on-line NMR analysis of chemical processes

Bruker expands capabilities of NMR-based Assure-RMS solution with launch of Chemometrics Module

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

BD MedMined Surveillance Advisor finishes first in Infection Control and Monitoring category

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Study could lead to potential new therapeutic target with fewer side effects for hypertension

Learning complex tactile tasks activates the visual cortex

Children who receive little to no nutrition during first week in intensive care recover faster

Aralez resubmits NDA package for YOSPRALA to FDA

Researchers provide new mechanism for age-related macular degeneration

Ibrutinib and idelalisib drugs for chronic lymphatic leukaemia can prolong survival time of high-risk patients

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

UCSF study marks important step toward finding cure for Ebola

Prognostic test could help lower cancer recurrence for colorectal patients

New blood test may potentially facilitate detection of Alzheimer's disease at early stage

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News